Global Bone Marrow Biopsy Market, By Product Type (Needles, Instruments, Biopsy Gun, Procedure Trays, Others), Procedure Type (Hip Biopsy, Breastbone (Sternum) Biopsy, Percutaneous Trephine Biopsy, Tibia (Shin) Biopsy, Others), Biopsy Type (Core Needle Biopsy, Vacuum-Assisted Biopsy (VAB), Fine Needle Aspiration Biopsy), Site (Posterior Iliac Crest, Anterior Iliac Crest, Calcaneus, Distal Tibia, Proximal Tibia, Proximal Humerus, Others), Technique (Flow Cytometry, Fluorescence In Situ Hybridization (Fish), Polymerase Chain Reaction (PCR), Karyotype Test, Other), Age (Geriatric, Adult, Pediatric), Application (Lymphoma Disease, Leukemia, Polycythemia Vera, Multiple Myeloma, Thrombocythemia, Myelofibrosis, Aplastic Anemia, Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Academic and Research Organizations, Others) – Industry Trends and Forecast to 2029
Bone Marrow Biopsy Market Analysis and Size
Increasing prevalence of blood disorders such as leukemia and aplastic anemia in both developed and developing countries are demanding the treatment of bone marrow biopsy. According to a 2015 National Cancer Institute report, an estimated 405,815 people in the United States had leukemia in 2015. However, inadequate bone marrow biopsy infrastructure is expected to impede markets in developing countries in the coming years. Bone marrow aspiration and bone marrow biopsy are invasive procedures that require strong technical skills to collect samples suitable for diagnostic processing and analysis. Needle size and caliber are one of the key factors in the technique chosen based on the patient's age, gender and weight.
Data Bridge Market Research analyses a significant growth in the global bone marrow biopsy market in the forecast period 2022-2029. The expected CAGR of global bone marrow biopsy market is tend to be around 6.3% in the mentioned forecast period. The market was valued at USD 1.10 billion in 2021, and it would grow upto USD 1.79 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Bone Marrow Biopsy Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product Type (Needles, Instruments, Biopsy Gun, Procedure Trays, Others), Procedure Type (Hip Biopsy, Breastbone (Sternum) Biopsy, Percutaneous Trephine Biopsy, Tibia (Shin) Biopsy, Others), Biopsy Type (Core Needle Biopsy, Vacuum-Assisted Biopsy (VAB), Fine Needle Aspiration Biopsy), Site (Posterior Iliac Crest, Anterior Iliac Crest, Calcaneus, Distal Tibia, Proximal Tibia, Proximal Humerus, Others), Technique (Flow Cytometry, Fluorescence In Situ Hybridization (Fish), Polymerase Chain Reaction (PCR), Karyotype Test, Other), Age (Geriatric, Adult, Pediatric), Application (Lymphoma Disease, Leukemia, Polycythemia Vera, Multiple Myeloma, Thrombocythemia, Myelofibrosis, Aplastic Anemia, Others), End User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Academic and Research Organizations, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
BD (US), Medtronic (Netherland), ARGON MEDICAL (US), Teleflex Incorporated (US), Cardinal Health (US), Merit Medical Systems (US), Cook (US), MDL SRL. (US), SOMATEX Medical Technologies GmbH (Deutschland), Biopsybell (US), STERYLAB S.r.l. (Italy), Tsunami Medical Srl (Italy), weLLgo Medical Products GmbH (Germany), Hiprove (Germnay), Shanghai Mekon Medical Devices Co., Ltd. (China), Egemen International (US)
|
|
Market Opportunities
|
|
Market Definition
Bone marrow biopsy helps detect abnormalities such as bone marrow cancer and blood disorders that can affect blood cells and bone marrow, such as leukemia and lymphoma. The bone marrow biopsy takes a bone marrow sample and a small amount of bone with a large needle. Bone marrow biopsy is an invasive procedure and requires qualified personnel to perform it. Thus, this procedure is of great benefit to the market and it is expected to grow manifolds in the future.
Global Bone Marrow Biopsy Market Dynamics
Drivers
- Increasing Prevalence of Blood Disorders
Increasing demand for bone marrow biopsy due to the increased incidence of blood disorders, is one of the key drivers driving the growth of the global bone marrow biopsy market. Research activities and clinical trial initiatives have helped boost the market for bone marrow biopsy around the world. The rising rate of early detection of these disorders are is driving the incidence of the treatment of bone marrow biopsy.
- Advances in Technology in Healthcare Sector
Technological advances in biopsy techniques will drive market growth in bone marrow biopsy market during the forecast period. For instance, single-use or disposable needles assure sterility for every procedure and also help in the prevention of cross contamination. This is expected to boost the segment during the forecast period. In addition, of all the biopsy techniques, the shave and saucerization biopsies are among the quickest and easiest to perform and it will have a positive impact on business growth during the forecast period.
Opportunities
- Increase in Diagnosis Rate of Early Detection
Bone marrow biopsy overshadows all techniques as it helps in early detection of the diseased condition. This early detection rate is driving the market high and is expected to see a high growth in the forecast period.
Restraints/Challenges
- High cost of biopsy tests
The market growth is rising high and is expected to grow in the mentioned forecast period. The major obstacle that may come in the way is the high cost of the procedures. People could feel restricted to go for this diagnosis method due to the high cost of bone marrow biopsies which could hinder the growth of the bone marrow industry in the future.
This global bone marrow biopsy market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global bone marrow biopsy market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Bone Marrow Biopsy Market
The COVID-19 has left an unprecedented global public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the forecast period. Our ongoing research is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included.
COVID-19 has left a positive impact on the lives of the patient population. During pandemic and post pandemic, the market flourished because the coronavirus may damage blood marrow cells in patients with severe COVID-19. For most of the patients with mild COVID-19, abnormal levels shifted back to normal during their hospital stay. However, in COVID-19 patients with more severe disease, the monocytes didn’t function properly. Hence, in this regard, the bone marrow biopsies were helpful.
Global Bone Marrow Biopsy Market Scope
The bone marrow biopsy market is segmented on the basis of product, procedure, biopsy type, site, technique, age, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Needles
- Instruments
- Biopsy Gun
- Procedure Trays
- Others
Procedure
- Hip Biopsy
- Breastbone (Sternum) Biopsy
- Percutaneous Trephine Biopsy
- Tibia (Shin) Biopsy
- Others
Biopsy Type
- Core Needle Biopsy
- Vacuum-Assisted Biopsy (VAB)
- Fine Needle Aspiration Biopsy
Site
- Posterior Iliac Crest
- Anterior Iliac Crest
- Calcaneus
- Distal Tibia
- Proximal Tibia
- Proximal Humerus
- Others
Technique
- Flow Cytometry
- Fluorescence In Situ Hybridization (Fish)
- Polymerase Chain Reaction (PCR)
- Karyotype Test
- Other
Age
- Geriatric
- Adult
- Pediatric
Application
- Lymphoma Disease
- Leukemia, Polycythemia Vera
- Multiple Myeloma
- Thrombocythemia
- Myelofibrosis
- Aplastic Anemia
- Others
End User
- Hospitals
- Diagnostic Centers
- Ambulatory Surgical Centers
- Academic and Research Organizations
- Others
Bone Marrow Biopsy Market Regional Analysis/Insights
The bone marrow biopsy market is analysed and market size insights and trends are provided by country, product, procedure, biopsy type, site, technique, age, application and end user as referenced above.
The major countries covered in the bone marrow biopsy market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the bone marrow biopsy market due to the high adoption and acceptance of bone marrow biopsy for the diagnosis of abnormal numbers of blood cells (red blood cells, white blood cells, or platelets) or lack of iron or cancers of the blood-forming tissue or cancers that have spread to the bone marrow or to find chemotherapy effects in the patients.
The Asia-Pacific region is expected to grow in the region with the highest growth rate during the forecast period of 2022-2029 due to increased numbers of bone marrow biopsies and increased prevalence of blood cancer.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Bone Marrow Biopsy Market Share Analysis
The bone marrow biopsy market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to bone marrow biopsy market.
Key players operating in the global bone marrow biopsy market include:
- BD(US)
- Medtronic(Netherland)
- ARGON MEDICAL(US)
- Teleflex Incorporated(US)
- Cardinal Health(US)
- Merit Medical Systems(US)
- Cook(US)
- MDL SRL.(US)
- SOMATEX Medical Technologies GmbH(Deutschland)
- Biopsybell(US)
- STERYLAB S.r.l.(Italy)
- Tsunami Medical Srl(Italy)
- weLLgo Medical Products GmbH(Germany)
- Hiprove (Germany)
- Shanghai Mekon Medical Devices Co., Ltd.(China)
- Egemen International(US)
SKU-